Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mr Strong Cough Syrup
- Development stage
- Unknown
- Lead developer
- CAPS Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mr Strong Cough Syrup is an over-the-counter (OTC) respiratory medication developed and manufactured by CAPS Holdings in Zimbabwe. Formulated as an oral syrup, it is indicated for the symptomatic relief of cough and other respiratory symptoms associated with the common cold. It is a well-established product in the Zimbabwean pharmaceutical market and is part of a broader respiratory portfolio that includes Mr Strong Capsules. While the product is confirmed to be a small molecule formulation, the specific active pharmaceutical ingredients and their corresponding biological targets are not publicly disclosed by the manufacturer.
- Brand names
- Mr Strong Cough Syrup
Beyond the preview
Go deeper on Mr Strong Cough Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mr Strong Cough Syrup.